SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-004791
Filing Date
2018-05-15
Accepted
2018-05-14 18:18:34
Documents
67
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mer-20180331x10q.htm 10-Q 1215685
2 EX-10.1 mer-20180331ex101e98559.htm EX-10.1 71659
3 EX-31.1 mer-20180331ex3117eb356.htm EX-31.1 11339
4 EX-31.2 mer-20180331ex312716ab7.htm EX-31.2 13047
5 EX-32.1 mer-20180331ex321abbe8c.htm EX-32.1 15999
  Complete submission text file 0001558370-18-004791.txt   6485970

Data Files

Seq Description Document Type Size
6 EX-101.INS mer-20180331.xml EX-101.INS 1490927
7 EX-101.SCH mer-20180331.xsd EX-101.SCH 63629
8 EX-101.CAL mer-20180331_cal.xml EX-101.CAL 41654
9 EX-101.DEF mer-20180331_def.xml EX-101.DEF 231094
10 EX-101.LAB mer-20180331_lab.xml EX-101.LAB 464490
11 EX-101.PRE mer-20180331_pre.xml EX-101.PRE 352341
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38129 | Film No.: 18832354
SIC: 2834 Pharmaceutical Preparations